image perfil
An in vitro Study Shows that Mouthwashes Containing CPC Reduce the Infectivity of Herpes Simplex Virus Type 1
image perfil
10min
image perfil
Information

Arrow green right A study conducted by the IrsiCaixa AIDS Research Institute and the Dentaid Research Center confirms the antiseptic and antiviral efficacy of cetylpyridinium chloride (CPC)
Arrow green right The use of mouthwashes containing CPC may offer an additional safe, simple and cost-effective way to reduce the infectivity and transmission potential of certain viruses
Arrow green right Herpes simplex type 1 virus (HSV-1) affects 67% of the world's population under 50 years of age and is the cause of cold sores, a highly contagious infection

Barcelona, 09 October 2023. An in vitro study carried out by the IrsiCaixa AIDS Research Institute and theDentaid Research Center has concluded that the use of mouthwashes containing cetylpyridinium chloride (CPC) can reduce herpes simplex type 1 virus (HSV-1) infection in cell cultures. CPC therefore plays a significant role in combating this virus, in addition to being effective as an oral antiseptic. The study, published in the scientific journal Viruses, reaffirms the ability of CPC to reduce the infectivity of certain viruses up to 100 times, given that the compound had already shown its effectiveness] against viruses such as influenza or SARS-CoV-2 in previous in vitro and in vivo studies.

The oral cavity is particularly susceptible to viral infections, especially since it is the main gateway for numerous pathogens into our body. "The in vitro experiments carried out in this study suggest that mouthwashes containing CPC could be effective at fighting viruses that cause oral infections, such as the herpes simplex virus (HSV-1)," highlights Dr Manuel Bañó, a researcher at the Dentaid Research Center.

To carry out this study, mouthwashes containing CPC were added to herpes virus cultures. Two minutes later – the time equivalent to the duration of mouthrinsing – the CPC was removed from the viral culture and these viruses were brought into contact with a human cell culture. “We tried to simulate a mouthrinse situation, but in the laboratory. We observed that the virus having come in contact with CPC loses its ability to infect these cells. However, if we do the same experiment, but without CPC, the virus continues infecting the cells,” explains Dr Ester Ballana-Guix, the principal investigator from IrsiCaixa.

Specifically, the trial was conducted with two mouthwash solutions, one for daily care with a concentration of 0.07% CPC, and another for temporary use in the adjunctive treatment of periodontal and peri-implant diseases, with a concentration of 0.05% CPC. It was confirmed in both instances that this component is capable of reducing the infectivity of the herpes virus, similar to what was shown in the case of the COVID-19 virus. "Although clinical trials are necessary to evaluate the protective role of CPC in people, we know that limiting the viral load in the oral cavity is important, not only to hinder reinfection and prevent complications in cases of severe infection, but also to reduce the oral transmission of viruses,” says Dr Ballana.

For all these reasons, rinsing with mouthwashes that contain this component could be an easy, affordable and safe additional resource to reduce the infectivity of highly prevalent viruses such as herpes.

This study was carried out in the microbiology area of the Dentaid Research Center, a global benchmark for oral health research aimed at generating scientific knowledge and its application in the development of innovative products. The Dentaid Research Center regularly conducts research and publishes studies that allow us to delve deeper into the improvement of oral health and the relationship that oral health has with general health.

Herpes simplex virus type 1

According to data from the World Health Organization (WHO) [iii] HSV-1 infection is estimated to affect 3.7 billion people worldwide under the age of 50.
It is a virus that spreads mainly through oral contact and causes infections such as cold sores or fever blisters in the mouth and adjacent areas. Most people infected with it either have no symptoms or experience mild symptoms, which means they can transmit the virus to others without being aware of it.

View the study here: https://www.mdpi.com/1999-4915/15/7/1433

Arrow green right A study conducted by the IrsiCaixa AIDS Research Institute and the Dentaid Research Center confirms the antiseptic and antiviral efficacy of cetylpyridinium chloride (CPC)
Arrow green right The use of mouthwashes containing CPC may offer an additional safe, simple and cost-effective way to reduce the infectivity and transmission potential of certain viruses
Arrow green right Herpes simplex type 1 virus (HSV-1) affects 67% of the world's population under 50 years of age and is the cause of cold sores, a highly contagious infection

Barcelona, 09 October 2023. An in vitro study carried out by the IrsiCaixa AIDS Research Institute and theDentaid Research Center has concluded that the use of mouthwashes containing cetylpyridinium chloride (CPC) can reduce herpes simplex type 1 virus (HSV-1) infection in cell cultures. CPC therefore plays a significant role in combating this virus, in addition to being effective as an oral antiseptic. The study, published in the scientific journal Viruses, reaffirms the ability of CPC to reduce the infectivity of certain viruses up to 100 times, given that the compound had already shown its effectiveness] against viruses such as influenza or SARS-CoV-2 in previous in vitro and in vivo studies.

The oral cavity is particularly susceptible to viral infections, especially since it is the main gateway for numerous pathogens into our body. "The in vitro experiments carried out in this study suggest that mouthwashes containing CPC could be effective at fighting viruses that cause oral infections, such as the herpes simplex virus (HSV-1)," highlights Dr Manuel Bañó, a researcher at the Dentaid Research Center.

To carry out this study, mouthwashes containing CPC were added to herpes virus cultures. Two minutes later – the time equivalent to the duration of mouthrinsing – the CPC was removed from the viral culture and these viruses were brought into contact with a human cell culture. “We tried to simulate a mouthrinse situation, but in the laboratory. We observed that the virus having come in contact with CPC loses its ability to infect these cells. However, if we do the same experiment, but without CPC, the virus continues infecting the cells,” explains Dr Ester Ballana-Guix, the principal investigator from IrsiCaixa.

Specifically, the trial was conducted with two mouthwash solutions, one for daily care with a concentration of 0.07% CPC, and another for temporary use in the adjunctive treatment of periodontal and peri-implant diseases, with a concentration of 0.05% CPC. It was confirmed in both instances that this component is capable of reducing the infectivity of the herpes virus, similar to what was shown in the case of the COVID-19 virus. "Although clinical trials are necessary to evaluate the protective role of CPC in people, we know that limiting the viral load in the oral cavity is important, not only to hinder reinfection and prevent complications in cases of severe infection, but also to reduce the oral transmission of viruses,” says Dr Ballana.

For all these reasons, rinsing with mouthwashes that contain this component could be an easy, affordable and safe additional resource to reduce the infectivity of highly prevalent viruses such as herpes.

This study was carried out in the microbiology area of the Dentaid Research Center, a global benchmark for oral health research aimed at generating scientific knowledge and its application in the development of innovative products. The Dentaid Research Center regularly conducts research and publishes studies that allow us to delve deeper into the improvement of oral health and the relationship that oral health has with general health.

Herpes simplex virus type 1

According to data from the World Health Organization (WHO) [iii] HSV-1 infection is estimated to affect 3.7 billion people worldwide under the age of 50.
It is a virus that spreads mainly through oral contact and causes infections such as cold sores or fever blisters in the mouth and adjacent areas. Most people infected with it either have no symptoms or experience mild symptoms, which means they can transmit the virus to others without being aware of it.

View the study here: https://www.mdpi.com/1999-4915/15/7/1433

Cookie Policy

We use our own and third-party cookies to analyse website usage and display ads tailored to your preferences based on a profile created from your browsing habits (e.g., pages visited).

You can accept or reject all cookies, or customise your preferences.